Hummmmm,,,,Bear,,,has RVX and Zenith carved themselves out as leaders in this field as much as wot KD has carved out for himself in general. If the science is a winner then KD will be the upcoming king of the epigenetic bioworld. My reasoning is....KD would be looking as to who gets the spoils and wot input gets a bigger gain down the road,,,,he has pocket change in RVX as it is,,,why at this stage would KD want to share any portion of the spoils with BP or any other deep pocketed partner?,,,,,billionaires generally dont have to share,,,,,so he wouldnt see any requirement on the upstream for outside sources business wise on the RVX play,,,,possibly the Zenith play,,,,,,RVX downstream sure,,but only in regional sales......does DM have an ace to play in the months to come??,,,,,,,I am not sure,,,looks to me like the existing RVX management team will not be controlling their future direction this time next year,,,,,,jmo...........perhaps others here have a scenario or hypothisis where our liabilities are converted without dilution,,,,lets hear them,,,,it generally takes big dollars to make big dollars!